Along with rapid weight loss, patients see other benefits and risks of GLP-1 drugs WPECGLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis NatureResearchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target statnews.com
